Side-by-side comparison of AI visibility scores, market position, and capabilities
Muna Therapeutics raised $75M in 2024 targeting microglial biology in Alzheimer's disease, using iPSC-derived microglia models to identify novel drug targets that modulate brain immune function.
Muna Therapeutics focuses on microglial biology — the specialized immune cells of the brain — as the key to developing disease-modifying Alzheimer's therapies beyond amyloid targeting. The company uses induced pluripotent stem cell (iPSC)-derived microglia as disease models to identify and validate novel drug targets implicated by Alzheimer's genetics (TREM2, PLCG2, BIN1, APOE). This platform enables the company to study microglial dysfunction at scale and run drug screens against human-relevant cellular models.
100ms is a live audio/video infrastructure platform with SDKs for React, iOS, Android, and Flutter, providing programmable rooms, recording, and live streaming for web and mobile apps.
100ms is a live audio and video infrastructure platform that provides developers with SDKs and APIs for embedding real-time communication features — video rooms, audio spaces, live streams, and recording — into web and mobile applications. The platform is designed around a room-based model where developers programmatically create, configure, and manage video rooms through a REST API, with client SDKs for React, iOS, Android, Flutter, and React Native handling the media layer. This abstraction allows teams to build fully custom video experiences with their own UI without dealing with WebRTC internals, TURN server management, or media server infrastructure.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.